Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a Double-Dose antibiotic cement slash infection risk after hip break?

NCT ID NCT05164081

First seen Mar 17, 2026 · Last updated Jun 19, 2026 · Updated 10 times

Summary

This study compares two types of antibiotic-loaded bone cement used during hip replacement surgery for broken hips. One cement contains a single antibiotic (gentamicin), the other contains two antibiotics (gentamicin and clindamycin). The goal is to see if the dual-antibiotic cement reduces the risk of deep joint infection within one year after surgery. About 7,000 patients aged 60 and older with displaced femoral neck fractures are taking part across multiple hospitals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMORAL NECK FRACTURES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Umeå University Hospital

    Umeå, Västerbotten County, Sweden

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

antibiotic-loaded bone cement (gentamicin with or without clindamycin)

What this could lead to

If it works, this could point toward a better way to prevent serious joint infections after hip fracture surgery, potentially reducing reoperations and deaths.

What could go wrong

This is a large trial, but results may not apply to all patients or hospitals. Adding a second antibiotic could increase side effects or antibiotic resistance without clear benefit.

Conditions

The condition(s) this trial relates to.

femoral neck fracture prosthesis-related infectious disease periprosthetic joint infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.